down arrow

Surgical Science Sweden AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014428512
SEK
31.56
-126.44 (-80.03%)

Jun 26

OME

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
BONESUPPORT HOLDING AB
MedCap AB
Getinge AB
Xvivo Perfusion AB
Biotage AB
CellaVision AB
Surgical Science Sweden AB
Genovis AB
Vitrolife AB
Bactiguard Holding AB
Elekta AB

Why is Surgical Science Sweden AB ?

1
The company has declared Negative results for the last 4 consecutive quarters
  • NET PROFIT(HY) At SEK 51.88 MM has Grown at -41.42%
  • ROCE(HY) Lowest at 1.17%
  • PRE-TAX PROFIT(Q) At SEK 21.63 MM has Fallen at -31.67%
2
Below par performance in long term as well as near term
  • Along with generating -78.43% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Surgical Science Sweden AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Surgical Science Sweden AB
-100.0%
-0.94
82.20%
OMX Stockholm 30
30.13%
1.89
15.95%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
56.77%
EBIT Growth (5y)
44.68%
EBIT to Interest (avg)
47.45
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.20
Tax Ratio
20.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.57%
ROE (avg)
4.01%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
0.39
EV to EBIT
7.67
EV to EBITDA
4.75
EV to Capital Employed
0.28
EV to Sales
1.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.70%
ROE (Latest)
2.01%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at -15.07 %

INVENTORY TURNOVER RATIO(HY)

Highest at 2.12 times

-20What is not working for the Company
NET PROFIT(HY)

At SEK 51.88 MM has Grown at -41.42%

ROCE(HY)

Lowest at 1.17%

PRE-TAX PROFIT(Q)

At SEK 21.63 MM has Fallen at -31.67%

RAW MATERIAL COST(Y)

Grown by 6.59% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.9 times

INTEREST(Q)

Highest at SEK 1.24 MM

Here's what is working for Surgical Science Sweden AB

Debt-Equity Ratio
Lowest at -15.07 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio
Highest at 2.12 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Surgical Science Sweden AB

Net Profit
At SEK 51.88 MM has Grown at -41.42%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (SEK MM)

Interest
At SEK 1.24 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Pre-Tax Profit
At SEK 21.63 MM has Fallen at -31.67%
over average net sales of the previous four periods of SEK 31.66 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (SEK MM)

Interest
Highest at SEK 1.24 MM
in the last five periods and Increased by inf% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Debtors Turnover Ratio
Lowest at 4.9 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 6.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."